Can we safely skip a Pre-Transplant bile duct scan? a trial tests the limits of simpler donor checks
NCT ID NCT07715500
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This trial studies whether omitting a routine magnetic resonance cholangiopancreatography (MRCP) scan in healthy living liver donors affects the rate of bile duct complications in transplant recipients. About 100 donors aged 18–55 will be randomly assigned to receive or skip the MRCP before surgery. The goal is to see if the scan is truly necessary for safe surgical planning or if intraoperative assessment alone is sufficient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Magnetic Resonance Cholangiopancreatography (MRCP) scan
- What this could lead to
- If skipping routine MRCP before liver donation proves safe, it could simplify donor evaluation and reduce healthcare costs without harming transplant outcomes.
- What could go wrong
- This is a single-center trial with 100 participants, so results may not apply broadly. The study is designed to test non-inferiority, not superiority, and missing a subtle bile duct variation could still increase recipient complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE AND CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
ILBS
RECRUITINGNew Delhi, 110070, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple drink before surgery might ease the Body's stress — a trial puts it to the test
- Could a common drug stop a rare liver disease from returning after transplant?
- Your genes may decide your new Liver's fate after MASH transplant
- New study examines artery complications in child liver transplants
- Texts and tools could help liver transplant patients stay on track
- Could your own fat cells protect your new liver?